K Kim

46PUBLICATIONS
240CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Aug 27, 2026
Comprehensive High-Sensitivity Mutation Profiling in MPNs: Diagnostic and Prognostic Implications.

|Aug 19, 2026
Baseline Plasma Cell-Free and Circulating Tumor DNA Across Lymphoma Subtypes and Its Prognostic Impact in Diffuse Large B-Cell Lymphoma

|Jul 06, 2026
Polatuzumab Vedotin Plus Rituximab, Gemcitabine, and Oxaliplatin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Results From the Phase III, Randomized POLARGO Trial.

|May 12, 2026
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis.

|Mar 23, 2026
Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study.

Jung Yeon Lee, Suein Choi, Seungpil Jung

|Dec 22, 2025
Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (CAPITAL).

Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin

Pageof 8

Frequent Collaborators

9 joint publications

June-Won Cheong

8 joint publications

Hyunsoo Cho

7 joint publications

Sung-Soo Yoon

7 joint publications

Ji Eun Jang